rcs-21
Nucleic acidexperimental
Clinical trial activity
1 trials · 2 clinical orgs · 0 marketing orgs
Phase 1
1
Phase 2
0
Phase 3
0
Phase 4
0
Earliest trial started Feb 18, 2025 (NCT06752122)
Timeline
2020s
- Jan 1, 2025
Earliest Phase 1 Sponsor(trial)
Indications
Mechanism of action
- microRNA 21INHIBITOR
microRNA 21 inhibitor
Chemistry & pharmacology
Oral
No
Parenteral
No
Topical
No
Clinical trials
| NCT ID | Phase | Start date | Sponsor(s) |
|---|---|---|---|
| NCT06752122 | Phase 1 | Feb 18, 2025 | LungenClinic Grosshansdorf, RNATICS GmbH |
Showing 1 of 1 trials
Page 1 / 1
Organizations
Research & Development (2)
| Organization | Org type | Trials | As lead sponsor | Phases | Earliest year |
|---|---|---|---|---|---|
| LungenClinic Grosshansdorf | Academic/Hospital | 1 | 0 | 1 | 2025 |
| RNATICS GmbH | For profit | 1 | 1 | 1 | 2025 |
2 organizations
Page 1 / 1